Navidea Biopharmaceuticals, Inc. (NYSE: NAVB), announced today that Jed A. Latkin has been appointed interim Chief Operating Officer effective April ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE